Position history for BAKER BROS. ADVISORS LP's holdings in ULTRAGENYX PHARMACEUTICAL IN
BAKER BROS. ADVISORS LP holds 2.8M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $63.8M as of 2025-Q4. RARE represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$63.8M
Current Shares
2.8M
Total Value Change
+$3.5M
Total Shares Change
+1.3M
Other major holders of RARE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 2.8M |
0.0% |
| $63.8M |
| 0.4% |
| $22.78 |
0 |
| 2025-Q3 | Unchanged | 2.8M | 0.0% | $83.4M | 0.6% | $30.36 | 0 |
| 2025-Q2 | Increased | 2.8M | +75.9% | $100.8M | 1.0% | $36.52 | 64 |
| 2025-Q1 | Unchanged | 1.6M | 0.0% | $57.1M | 0.6% | $37.82 | 0 |
| 2024-Q4 | Unchanged | 1.6M | 0.0% | $66.3M | 0.7% | $42.27 | 0 |
| 2024-Q3 | Increased | 1.6M | +7.5% | $87.6M | 0.9% | $54.43 | 45 |
| 2024-Q2 | Unchanged | 1.5M | 0.0% | $60.3M | 0.8% | $41.10 | 0 |